Featured Articles

Videos
June 10, 2021
Briana Choi, PharmD, discusses results from a study evaluating the cost-effectiveness of adjunctive maintenance therapy with osimertinib in resected EGFR-…
Blog
June 10, 2021
Justin Kerley, BA, and Theresa Schmidt, MA, PMP, CSPO, explore the dynamics of patient and caregiver engagement via social media and consider how quality measures and other quality tools can help maximize the benefits of social media while reducing the risks.
Videos
June 10, 2021
David Barrington, MD, discusses results from a study suggesting lenvatinib plus pembrolizumab is not a cost-effective treatment option for patients with recurrent endometrial cancer.
Conference Coverage
June 10, 2021
Rituximab-abbs may have more economic benefits compared to reference rituximab in patients with NHL, CLL, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.
News
June 07, 2021
Study findings highlight substantial economic burden incurred by Medicare among patients with CLL who initiated systemic therapy in routine practice, citing adverse events as a large contributor to the high overall cost of CLL management.